XOMA Royalty Corporation (XOMAP)

NASDAQ: XOMAP · Real-Time Price · USD · Preferred Stock
25.81
+0.14 (0.56%)
Jun 27, 2025, 4:00 PM - Market closed
0.56%
Market Cap 328.97M
Revenue (ttm) 42.91M
Net Income (ttm) -8.63M
Shares Out 11.97M
EPS (ttm) -0.73
PE Ratio n/a
Forward PE n/a
Dividend $2.16 (8.36%)
Ex-Dividend Date Apr 3, 2025
Volume 608
Open 25.81
Previous Close 25.66
Day's Range 25.81 - 25.81
52-Week Range 24.96 - 26.51
Beta 0.94
Analysts n/a
Price Target n/a
Earnings Date May 7, 2025

About XOMAP

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1981
Employees 13
Stock Exchange NASDAQ
Ticker Symbol XOMAP
Full Company Profile

News

There is no news available yet.